The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity' for repurposing a clinically used oncological drug for the experimental therapy of sepsis (2019)
- Authors:
- USP affiliated authors: BARBEIRO, DENISE FREDIANI - FM ; SORIANO, Francisco Garcia - FM
- Unidade: FM
- DOI: 10.1016/j.phrs.2019.104263
- Subjects: TRANSFERASES; CAMUNDONGOS; CHOQUE SÉPTICO; ESTRESSE OXIDATIVO; LIGADURA; PUNÇÕES
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Pharmacological research
- ISSN: 1043-6618
- Volume/Número/Paginação/Ano: v. 145, article ID UNSP 104263, 29p, 2019
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
- Licença: publisher-specific-oa
-
ABNT
AHMAD, Akbar et al. The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity' for repurposing a clinically used oncological drug for the experimental therapy of sepsis. Pharmacological research, v. 145, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.phrs.2019.104263. Acesso em: 28 dez. 2025. -
APA
Ahmad, A., Vieira, J. de C., Mello, A. H. de, Lima, T. M. de, Ariga, S. K., Barbeiro, D. F., et al. (2019). The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity' for repurposing a clinically used oncological drug for the experimental therapy of sepsis. Pharmacological research, 145. doi:10.1016/j.phrs.2019.104263 -
NLM
Ahmad A, Vieira J de C, Mello AH de, Lima TM de, Ariga SK, Barbeiro DF, Barbeiro HV, Szczesny B, Toro G, Druzhyna N. The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity' for repurposing a clinically used oncological drug for the experimental therapy of sepsis [Internet]. Pharmacological research. 2019 ; 145[citado 2025 dez. 28 ] Available from: https://doi.org/10.1016/j.phrs.2019.104263 -
Vancouver
Ahmad A, Vieira J de C, Mello AH de, Lima TM de, Ariga SK, Barbeiro DF, Barbeiro HV, Szczesny B, Toro G, Druzhyna N. The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity' for repurposing a clinically used oncological drug for the experimental therapy of sepsis [Internet]. Pharmacological research. 2019 ; 145[citado 2025 dez. 28 ] Available from: https://doi.org/10.1016/j.phrs.2019.104263 - The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity' for repurposing a clinically used oncological drug for the experimental therapy of sepsis
- Treg and NK cells related cytokines are associated with deep rectosigmoid endometriosis and clinical symptoms related to the disease
- Participação da célula B-1 na resposta inflamatória ao lipopolissacáride
- Consumption of margarine and butter and lipid profiles and inflammatory of patients with metabolic syndrome
- Correlations between food intake, lipid profile and inflammation in patients with metabolic syndrome
- Hypertonic saline solution reduces the inflammatory response in endotoxemic rats
- Hypertonic solution-induced preconditioning reduces inflammation and mortality rate
- Expressão de TLR2 e TLR4 e remodelamentoo da matriz extracelular em pulmões de ratos endotoxêmicos
- Pequi fruit (Caryocar Brasiliense Camb) protects against oxidative stress induced by urethane in a experimental model of lung cancer
- Reposição volêmica e resposta inflamatória em ratos endotoxêmicos
Informações sobre o DOI: 10.1016/j.phrs.2019.104263 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas